-
High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach.
The Journal of biological chemistry 20121102
-
Variable-temperature 17O NMR studies allow quantitative evaluation of molecular dynamics in organic solids.
Journal of the American Chemical Society 20120905
-
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility.
Therapeutics and clinical risk management 20120101
-
Metal chaperones: a holistic approach to the treatment of Alzheimer's disease.
Frontiers in psychiatry 20120101
-
Alzheimer's disease and the amyloid cascade hypothesis: a critical review.
International journal of Alzheimer's disease 20120101
-
Alzheimer's disease: a clinical practice-oriented review.
Frontiers in neurology 20120101
-
Probing and trapping a sensitive conformation: amyloid-β fibrils, oligomers, and dimers.
Journal of Alzheimer's disease : JAD 20120101
-
Calcium acamprosate: a triclinic polymorph.
Acta crystallographica. Section E, Structure reports online 20111201
-
Alzheimer's disease: pathological mechanisms and recent insights.
Current neuropharmacology 20111201
-
Current and emerging drug treatment options for Alzheimer's disease: a systematic review.
Drugs 20111022
-
Reversed-phase liquid chromatographic determination of tramiprosate in rat plasma using evaporative light scattering detector.
Biomedical chromatography : BMC 20110801
-
Precolumn derivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: application to pharmacokinetics.
Journal of pharmaceutical and biomedical analysis 20110515
-
Gas-phase binding energies for non-covalent Aβ-40 peptide/small molecule complexes from CID mass spectrometry and RRKM theory.
Physical chemistry chemical physics : PCCP 20110321
-
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty.
PLoS medicine 20110301
-
Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
Journal of molecular biology 20110225
-
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).
Archives of medical science : AMS 20110201
-
Investigational drugs for the treatment of AD: what can we learn from negative trials?
Alzheimer's research & therapy 20110101
-
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment.
International journal of Alzheimer's disease 20110101
-
Neurosteroid Binding Sites on the GABA(A) Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence.
Advances in pharmacological sciences 20110101
-
Neuroregenerative mechanisms of allopregnanolone in Alzheimer's disease.
Frontiers in endocrinology 20110101
-
Determination of the natural abundance δ15N of taurine by gas chromatography-isotope ratio measurement mass spectrometry.
Rapid communications in mass spectrometry : RCM 20101215
-
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Bioorganic & medicinal chemistry letters 20101101
-
The persisting burden of intracerebral haemorrhage: can effective treatments be found?
PLoS medicine 20101001
-
Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.
Journal of the American Society for Mass Spectrometry 20100901
-
[Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100701
-
Update on the pharmacological treatment of Alzheimer's disease.
Current neuropharmacology 20100301
-
Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate.
Alcoholism, clinical and experimental research 20100101
-
Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy.
Journal of Alzheimer's disease : JAD 20100101
-
Reciprocal regulation between taurine and glutamate response via Ca2+-dependent pathways in retinal third-order neurons.
Journal of biomedical science 20100101
-
Regulation of in vitro Aβ1-40 aggregation mediated by small molecules.
Journal of Alzheimer's disease : JAD 20100101
-
Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study.
The journal of nutrition, health & aging 20091101
-
Homotaurine: a failed drug for Alzheimer's disease and now a nutraceutical for memory protection.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091101
-
Homotaurine metabolized to 3-sulfopropanoate in Cupriavidus necator H16: enzymes and genes in a patchwork pathway.
Journal of bacteriology 20091001
-
Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.
The journal of nutrition, health & aging 20090601
-
Drug development for Alzheimer's disease: where are we now and where are we headed?
The American journal of geriatric pharmacotherapy 20090601
-
Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience.
The journal of nutrition, health & aging 20090401
-
Multivalent & multifunctional ligands to beta-amyloid.
Current pharmaceutical design 20090101
-
Recent developments in Alzheimer's disease therapeutics.
BMC medicine 20090101
-
The effects of taurine, taurine homologs and hypotaurine on cell and membrane antioxidative system alterations caused by type 2 diabetes in rat erythrocytes.
Advances in experimental medicine and biology 20090101
-
The effects of taurine, hypotaurine, and taurine homologs on erythrocyte morphology, membrane fluidity and cytoskeletal spectrin alterations due to diabetes, alcoholism and diabetes-alcoholism in the rat.
Advances in experimental medicine and biology 20090101
-
Alzheimer's disease therapeutic research: the path forward.
Alzheimer's research & therapy 20090101
-
Present and prospective clinical therapeutic regimens for Alzheimer's disease.
Neuropsychiatric disease and treatment 20080801
-
[New approaches for the development of anti-Alzheimer's disease drugs based on the cholinergic hypothesis and amyloid hypothesis].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080501
-
Assimilation of homotaurine-nitrogen by Burkholderia sp. and excretion of sulfopropanoate.
FEMS microbiology letters 20080201
-
Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.
BMC neuroscience 20080101
-
Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation.
Neuroscience letters 20071218
-
Pharmacogenetic aspects of addictive behaviors.
Dialogues in clinical neuroscience 20071201
-
Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.
Current neuropharmacology 20071201
-
Current therapeutic options for Alzheimer's disease.
Current genomics 20071201
-
Progress update: Pharmacological treatment of Alzheimer's disease.
Neuropsychiatric disease and treatment 20071001
-
The amyloid beta ion channel hypothesis of Alzheimer's disease.
Neuropsychiatric disease and treatment 20071001
-
Therapies for Alzheimer's disease.
Nature reviews. Drug discovery 20070501
-
Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.
Neurobiology of aging 20070401
-
Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure.
BMC developmental biology 20070101
-
Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon.
Primary care companion to the Journal of clinical psychiatry 20070101
-
Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.
Molecular neurodegeneration 20070101
-
Acamprosate: a new tool in the battle against alcohol dependence.
Neuropsychiatric disease and treatment 20061201
-
A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.
Neurology 20061128
-
Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology 20061001
-
Substrate specificity of the amino acid transporter PAT1.
Amino acids 20060901
-
Influence of a proton gradient on the transport kinetics of the H+/amino acid cotransporter PAT1 in Caco-2 cells.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20060701
-
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
-
Tramiprosate.
Drugs of today (Barcelona, Spain : 1998) 20060501
-
Diazepam inhibits the induction and maintenance of LTP of C-fiber evoked field potentials in spinal dorsal horn of rats.
Neuropharmacology 20060201
-
Molecule of the month. Tramiprosate.
Drug news & perspectives 20060101
-
A phase 2 study of tramiprosate for cerebral amyloid angiopathy.
Alzheimer disease and associated disorders 20060101
-
The regulation of alpha-MSH release by GABA is mediated by a chloride-dependent [Ca2+]c increase in frog melanotrope cells.
Peptides 20051001
-
Inhibitors arrest myofibrillogenesis in skeletal muscle cells at early stages of assembly.
Cell motility and the cytoskeleton 20040901
-
Taurine-induced long-lasting potentiation in the rat hippocampus shows a partial dissociation from total hippocampal taurine content and independence from activation of known taurine transporters.
Journal of neurochemistry 20040601
-
Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
The Journal of pharmacology and experimental therapeutics 20040401
-
Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain.
British journal of pharmacology 20030301
-
Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation.
Amino acids 20020601
-
Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.
European journal of pharmacology 20020215
-
Interactions between taurine and ethanol in the central nervous system.
Amino acids 20020101
-
Role of K+ -channels in homotaurine-induced analgesia.
Fundamental & clinical pharmacology 20010601
-
Synthesis and characterization of N,N-dichlorinated amino acids: taurine, homotaurine, GABA and L-leucine.
Neurochemical research 20010601
-
Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons.
Journal of biomedical science 20010101
-
Taurine is a weak scavenger of peroxynitrite and does not attenuate sodium nitroprusside toxicity to cells in culture.
Amino acids 20010101
-
Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
The Journal of clinical psychiatry 20010101
-
GABAA receptor-mediated positive inotropism in guinea-pig isolated left atria: evidence for the involvement of capsaicin-sensitive nerves.
British journal of pharmacology 19890501
-
Baclofen induces catatonia in rats.
Neuropharmacology 19870901
-
The effect of peripherally administered GABA on noradrenaline-induced reflex vagal bradycardia in urethane anaesthetized rats.
General pharmacology 19850101
